Abstract
Little was known about the arsenic metabolism and arsenic methylation associated with the changes of skin lesions after reducing the arsenic in drinking water (WAs). Therefore, urinary concentrations and proportions of arsenic species were determined for recovery (RC), improvement (IC), persistent (PE), aggravation (AC), new incidence (NC), and no sign (HC) groups based on the changes of skin lesions between before (in 2004) and after (in 2017) WAs reduction. The results indicate that the urinary concentrations of inorganic arsenic (iAs), monomethylarsonic acid (MMA), dimethylarsinic acid (DMA), and total arsenic (TAs) were much higher for RC and IC groups than for the other groups in 2004, while these values varied slightly among the groups in 2017. The urinary %iAs of all the groups was significantly decreased after WAs reduction. In contrast, the urinary %DMA of RC, IC, AC, and NC groups was increased. From 2004 to 2017, the PE and HC groups had lower decrease rate of %iAs and %MMA, and increase rate of %DMA, primary methylation index (PMI), and secondary methylation index (SMI) after WAs reduction. The adjusted odd ratios (ORs) showed that the RC, IC, AC, and NC groups were positively related with %iAs and %MMA and were negatively correlated with %DMA, PMI, and SMI before WAs reduction. It can be concluded that higher urinary %iAs and %MMA before WAs reduction increased the probability of skin lesions recovery and improvement, and the risks of skin lesions aggravation and incidence. Higher increase rate of urinary %DMA was positively associated with of skin lesions recovery and improvement. Moreover, higher urinary %iAs and %MMA or lower increase rate of urinary %DMA might increase the risk of skin lesions aggravation.
Similar content being viewed by others
References
Agusa T, Kunito T, Minh TB, Trang PTK, Iwata H, Viet PH, Tanabe S (2009) Relationship of urinary arsenic metabolites to intake estimates in residents of the Red River Delta, Vietnam. Environ Pollut 157:396–403
Ahsan H, Chen Y, Kibriya MG, Slavkovich V, Parvez F, Jasmine F, Gamble MV, Graziano JH (2007) Arsenic metabolism, genetic susceptibility, and risk of premalignant skin lesions in Bangladesh. Cancer Epidemiol Biomark Prev 16:1270–1278
Celik I, Gallicchio L, Boyd K, Lam TK, Matanoski G, Tao X, Shiels M, Hammond E, Chen L, Robinson KA, Caulfield LE, Herman JG, Guallar E, Alberg AJ (2008) Arsenic in drinking water and lung cancer: a systematic review. Environ Res 108:48–55
Chen Y, Wu F, Liu M, Parvez F, Slavkovich V, Eunus M, Ahmed A, Argos M, Islam T, Rakibuz-Zaman M, Hasan R, Sarwar G, Levy D, Graziano J, Ahsan H (2013) A prospective study of arsenic exposure, arsenic methylation capacity, and risk of cardiovascular disease in Bangladesh. Environ Health Perspect 121:832–838
Gamble MV, Liu X, Ahsan H, Pilsner JR, Ilievski V, Slavkovich V, Parvez F, Levy D, Factor-Litvak P, Graziano JH (2005) Folate, homocysteine, and arsenic metabolism in arsenic-exposed individuals in Bangladesh. Environ Health Perspect 113:1683–1688
Hopenhayn-Rich C, Biggs ML, Kalman DA, Moore LE, Smith AH (1996) Arsenic methylation patterns before and after changing from high to lower concentrations of arsenic in drinking water. Environ Health Perspect 104:1200–1207
Huang Y, Tseng C, Huang Y, Yang M, Chen C, Hsueh Y (2007) Arsenic methylation capability and hypertension risk in subjects living in arseniasis-hyperendemic areas in southwestern Taiwan. Toxicol Appl Pharmacol 218:135–142
Huang Y, Huang Y, Hsueh Y, Wang JT, Yang M, Chen C (2009) Changes in urinary arsenic methylation profiles in a 15-year interval after cessation of arsenic ingestion in southwest Taiwan. Environ Health Perspect 117:1860–1866
Kapaj S, Peterson H, Liber K, Bhattacharya P (2006) Human health effects from chronic arsenic poisoning—a review. J Environ Sci Health A 41:2399–2428
Karagas MR, Gossai A, Pierce B, Ahsan H (2015) Drinking water arsenic contamination, skin lesions, and malignancies: a systematic review of the global evidence. Curr Environ Health Rep 2:52–68
Kile ML, Hoffman E, Rodrigues EG, Breton CV, Quamruzzaman Q, Rahman M, Mahiuddin G, Hsueh YM, Christiani DC (2011) A pathway-based analysis of urinary arsenic metabolites and skin lesions. Am J Epidemiol 173(7):778–786
Li X, Li B, Xu Y, Wang Y, Jin Y, Itoh T, Yoshida T, Sun G (2011) Arsenic methylation capacity and its correlation with skin lesions induced by contaminated drinking water consumption in residents of chronic arsenicosis area. Environ Toxicol 26:118–123
López-Carrillo L, Hernández-Ramírez RU, Gandolfi AJ, Ornelas-Aguirre JM, Torres-Sánchez L, Cebrian ME (2014) Arsenic methylation capacity is associated with breast cancer in northern Mexico. Toxicol Appl Pharmacol 280:53–59
Löveborn HS, Kippler M, Lu Y, Ahmed S, Kuehnelt D, Raqib R, Vahter M (2016) Arsenic metabolism in children differs from that in adults. Toxicol Sci 152(1):29–39
Melak D, Ferreccio C, Kalman D, Parra R, Acevedo J, Pérez L, Cortés S, Smith AH, Yuan Y, Liaw J, Steinmaus C (2014) Arsenic methylation and lung and bladder cancer in a case-control study in northern Chile. Toxicol Appl Pharmacol 274:225–231
Pierce BL, Tong L, Argos M, Gao J, Jasmine F, Roy S, Paul-Brutus R, Rahaman R, Rakibuz-Zaman M, Parvez F, Ahmed A, Quasem I, Hore SK, Alam S, Islam T, Harjes J, Sarwar G, Slavkovich V, Gamble MV, Chen Y, Yunus M, Rahman M, Baron JA, Graziano JH, Ahsan H (2013) Arsenic metabolism efficiency has a causal role in arsenic toxicity: Mendelian randomization and gene-environment interaction. Int J Epidemiol 42:1862–1872
Seow WJ, Pan WC, Kile ML, Baccarelli AA, Quamruzzaman Q, Rahman M, Mahiuddin G, Mostofa G, Lin X, Christiani DC (2013) Arsenic reduction in drinking water and improvement in skin lesions: a follow-up study in Bangladesh. Environ Health Perspect 121:1733–1738
Somé IT, Sakira AK, Ouédraogo M, Ouédraogo TZ, Traoré A, Sondo B, Guissou PI (2012) Arsenic levels in tube-wells water, food, residents’ urine and the prevalence of skin lesions in Yatenga province, Burkina Faso. Interdiscip Toxicol 5(1):38–41
Steinmaus C, Yuan Y, Kalman D, Rey OA, Skibola C, Dauphine D, Basu A, Porter KE, Hubbard A, Bates M, Smith MT, Smith AH (2010) Individual differences in arsenic metabolism and lung cancer in a case-control study in Cordoba, Argentina. Toxicol Appl Pharmacol 247:138–145
Sun G, Xu Y, Li X, Jin Y, Li B, Sun X (2007) Urinary arsenic metabolites in children and adults exposed to arsenic in drinking water in Inner Mongolia, China. Environ Health Perspect 115:648–652
Tseng C (2007) Arsenic methylation, urinary arsenic metabolites and human diseases: current perspective. J Environ Sci Health C 25:1–22
US Environmental Protection Agency (US EPA) (2001) Technical fact sheet: proposed rule for arsenic in drinking water. US Environmental Protection Agency, Washington, DC
Wei B, Yu J, Li H, Yang L, Xia Y, Wu K, Gao J, Guo Z, Cui N (2016) Arsenic metabolites and methylation capacity among individuals living in a rural area with endemic arseniasis in Inner Mongolia, China. Biol Trace Elem Res 170:300–308
Wei B, Ye B, Yu J, Yang L, Li H, Xia Y, Wu K (2017) Blood pressure associated with arsenic methylation and arsenic metabolism caused by chronic exposure to arsenic in tube well water. Biomed Environ Sci 30(5):333–342
Wen J, Wen W, Li L, Liu H (2012) Methylation capacity of arsenic and skin lesions in smelter plant workers. Environ Toxicol Pharmacol 34:624–630
World Health Organization (WHO) (1993) Guidelines for drinking water quality. WHO, Geneva
Yang L, Chai Y, Yu J, Wei B, Xia Y, Wu K, Gao J, Guo Z, Cui N (2017) Associations of arsenic metabolites, methylation capacity, and skin lesions caused by chronic exposure to high arsenic in tube well water. Environ Toxicol 32:28–36
Zhang Q, Wang D, Zheng Q, Zheng Y, Wang H, Xu Y, Li X, Sun G (2014a) Joint effects of urinary arsenic methylation capacity with potential modifiers on arsenicosis: a cross-sectional study from an endemic arsenism area in Hohhot Basin, northern China. Environ Res 132:281–289
Zhang Q, Li Y, Liu J, Wang D, Zheng Q, Sun G (2014b) Differences of urinary arsenic metabolites and methylation capacity between individuals with and without skin lesions in Inner Mongolia, northern China. Int J Environ Res Public Health 11:7319–7332
Funding
The work described in this paper was financially supported by the National Natural Science Foundation of China (Grant No. 41601559) and the State Key Program of National Natural Science of China (Grant No. 41230749).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Conflict of interest
The authors declare that they have no competing interests.
Additional information
Responsible editor: Philippe Garrigues
Rights and permissions
About this article
Cite this article
Wei, B., Yu, J., Kong, C. et al. Effects of arsenic methylation and metabolism on the changes of arsenic-related skin lesions. Environ Sci Pollut Res 25, 24394–24402 (2018). https://doi.org/10.1007/s11356-018-2512-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11356-018-2512-2